CSL (ASX: CSL) shares plunged sharply on Monday after the Australian biopharmaceutical giant downgraded its fiscal 2026 ...
CSL Ltd. plunged the most on record after the Australian biotechnology company cut its full-year outlook and flagged about $5 ...
CSL (ASX:CSL) has outlined a restructuring plan that includes separating its Seqirus influenza vaccine business into a standalone entity. The company is also planning workforce reductions and the ...
CSL shares plunged again this week after a major profit downgrade. So where does Macquarie see the share price going from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results